Skip to main content

Advertisement

Log in

Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Although the role of Krüppel-like factor 17 (KLF17) in regulating epithelial–mesenchymal transition (EMT) has been explored in breast cancer, its influence on primary hepatocellular carcinoma (HCC) remains unclear. This study aims to investigate the expression status of KLF17 in hepatocellular carcinoma (HCC) and the correlation between KLF17 expression and metastatic potential of HCC. KLF17 expression in HCC and adjacent liver tissues was studied by real-time PCR and Western blot, and the relationship between KLF17 expression and the clinicopathological features of HCC was evaluated in 60 patients. By using RNA interference technique, the correlation of KLF17 expression and metastatic potential was investigated by down-regulating KLF17 expression in HepG2 cells, and the effects of KLF17 down-regulation on cell migration, and invasion were then analyzed. Furthermore, the correlation between KLF17 expression and the surgical outcomes of a cohort of HCC patients was analyzed. Reduced expression of KLF17 is associated with a short survival time in clinical patients (P = 0.034). Low KLF17 expression is related to tumor T stage (P = 0.045), tumor size (P = 0.027), lymph node stage (P = 0.030), M stage (P = 0.048), and portal vein tumor thrombosis significantly in HCC. Reduced expression of KLF17 promoted motility and invasion ability of HepG2 cells and changed the expression of E-cadherin, ZO-1, Snai1, and vimentin (genes are associated with EMT). Overall, these findings suggest a repressing role of KLF17 in tumor invasion and a new prognostic indicator in directing therapy. It deserves further exploration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–87.

    Article  PubMed  CAS  Google Scholar 

  2. Liotta LA. Mechanisms of cancer invasion and metastasis. Important advances in oncology. 1985:28–41. (Epub 1985/01/01).

  3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90.

    Article  PubMed  CAS  Google Scholar 

  4. Suske G, Bruford E, Philipsen S. Mammalian SP/KLF transcription factors: bring in the family. Genomics. 2005;85(5):551–6.

    Article  PubMed  CAS  Google Scholar 

  5. van Vliet J, Crofts LA, Quinlan KG, Czolij R, Perkins AC, Crossley M. Human KLF17 is a new member of the Sp/KLF family of transcription factors. Genomics. 2006;87(4):474–82.

    Article  PubMed  Google Scholar 

  6. Kim J, Shin S, Subramaniam M, Bruinsma E, Kim TD, Hawse JR, et al. Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. Biochem Biophys Res Commun. 2010;401(3):412–6.

    Article  PubMed  CAS  Google Scholar 

  7. Spittau G, Happel N, Behrendt M, Chao TI, Krieglstein K, Spittau B. Tieg1/Klf10 is upregulated by NGF and attenuates cell cycle progression in the pheochromocytoma cell line PC12. J Neurosci Res. 2010;88(9):2017–25.

    PubMed  CAS  Google Scholar 

  8. Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4(2):206.

    Article  PubMed  Google Scholar 

  9. Humbert M, Halter V, Shan D, Laedrach J, Leibundgut EO, Baerlocher GM, et al. Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leukemia Res. 2011;35(7):909–13.

    Article  CAS  Google Scholar 

  10. McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–81.

    Article  PubMed  CAS  Google Scholar 

  11. Antin PB, Pier M, Sesepasara T, Yatskievych TA, Darnell DK. Embryonic expression of the chicken Kruppel-like (KLF) transcription factor gene family. Dev Dyn. 2010;239(6):1879–87.

    Article  PubMed  CAS  Google Scholar 

  12. X-d Cai, Y-b Zhou, L-x Huang, Q-l Zeng, L-j Zhang, Q-q Wang, et al. Reduced expression of Krüppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma. Biochem Biophys Res Comm. 2012;418(1):67–73.

    Article  Google Scholar 

  13. Gumireddy K, Li A, Gimotty PA, Klein-Szanto AJ, Showe LC, Katsaros D, et al. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol. 2009;11(11):1297–304.

    Article  PubMed  CAS  Google Scholar 

  14. Fernandez-Zapico ME, Lomberk GA, Tsuji S, DeMars CJ, Bardsley MR, Lin YH, et al. A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth. Biochem J. 2011;435(2):529–37.

    Article  PubMed  CAS  Google Scholar 

  15. Vetter D, Cohen-Naftaly M, Villaneuva A, Lee YA, Kocabayoglu P, Hannivoort R, et al. Enhanced hepatocarcinogenesis in mouse models and human HCC by coordinate KLF6 depletion and increased mRNA splicing. Hepatology. 2012. (Epub 2012/04/27).

  16. Tarocchi M, Hannivoort R, Hoshida Y, Lee UE, Vetter D, Narla G, et al. Carcinogen-induced hepatic tumors in KLF6 ± mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. Hepatology. 2011;54(2):522–31.

    Article  PubMed  CAS  Google Scholar 

  17. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–15.

    Article  PubMed  CAS  Google Scholar 

  18. Sleeman JP, Thiery JP. SnapShot: the epithelial-mesenchymal transition. Cell. 2011;145(1):162.

    Article  PubMed  CAS  Google Scholar 

  19. Ishiyama N, Lee SH, Liu S, Li GY, Smith MJ, Reichardt LF, et al. Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell–cell adhesion. Cell. 2010;141(1):117–28.

    Article  PubMed  CAS  Google Scholar 

  20. Patel SD, Ciatto C, Chen CP, Bahna F, Rajebhosale M, Arkus N, et al. Type II cadherin ectodomain structures: implications for classical cadherin specificity. Cell. 2006;124(6):1255–68.

    Article  PubMed  CAS  Google Scholar 

  21. Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P, Resink TJ. A guide and guard: the many faces of T-cadherin. Cell Signal. 2009;21(7):1035–44.

    Article  PubMed  CAS  Google Scholar 

  22. Chan DW, Lee JMF, Chan PCY, Ng IOL. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Int J Cancer. 2008;123(5):1043–52.

    Article  PubMed  CAS  Google Scholar 

  23. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033–46.

    Article  PubMed  CAS  Google Scholar 

  24. Savagner P. The epithelial–mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010;21(Suppl 7):789–92.

    Google Scholar 

  25. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011;17(9):1101–8.

    Article  PubMed  CAS  Google Scholar 

  26. Ellenrieder V. TGFβ-regulated gene expression by smads and Sp1/KLF-like transcription factors in cancer. Anti cancer Res. 2008;28(3):1531–9.

    CAS  Google Scholar 

Download references

Acknowledgments

We thank Professor Zhiyong Huang of the Department of Surgery (Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, China) for the providing the samples of patients with HCC.

Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, “Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.”

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to De-An Tian or Mei Liu.

Additional information

Fu-Yao Liu and Yue-Ling Deng contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, FY., Deng, YL., Li, Y. et al. Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma. Med Oncol 30, 425 (2013). https://doi.org/10.1007/s12032-012-0425-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-012-0425-3

Keywords

Navigation